Zhang L.
43
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2007 | 2 |
| 2008 | 3 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Cáncer | 6 |
| Nanopartícula | 3 |
| Biotecnología | 1 |
| Farmacología | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 5 |
| Ingeniería y operaciones afines | 2 |
| Química analítica | 1 |
| Ingeniería civil | 1 |
| Medicina y salud | 1 |
| Química física | 1 |
| Enfermedades | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Frank Alexis | 5 |
| Farokhzad O.C. | 5 |
| Langer R.S. | 4 |
| Basto P.A. | 3 |
| Gu F.X. | 3 |
| Radovic-Moreno A.F. | 3 |
| Wang A.Z. | 3 |
| Jon S. | 2 |
| Bagalkot V. | 2 |
| Levy-Nissenbaum E. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Targeted aptamer-nanoparticles to diminish drug resistance of cancer cells in vitro study
Conference ObjectAbstract: Using prostate cancer as a model, we report the drug release of Docetaxel and doxorubicin from aptamPalabras claves:aptamer, doxorubicin, Poly (D,L-lactic-co-glycolic acid) (PLGA), Prostate cancer, Targeted deliveryAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Langer R.S., Zhang L.Fuentes:scopusCo-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates
ArticleAbstract: (Figure Presented) Herein we report a novel targeted drug delivery system consisting of nanoparticlePalabras claves:Antitumor agents, conjugation, Dual drug delivery, Nanoparticles, Targeted therapyAutores:Bagalkot V., Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Langer R.S., Radovic-Moreno A.F., Zhang L.Fuentes:scopusSelf-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform
ArticleAbstract: We report the engineering of a novel lipid-polymer hybrid nanoparticle (NP) as a robust drug deliverPalabras claves:drug delivery, Liposome, Nanoprecipitation, Polymeric nanoparticle, self-assemblyAutores:Chan J.M., Farokhzad O.C., Frank Alexis, Gu F.X., Langer R.S., Radovic-Moreno A.F., Rhee J.W., Wang A.Z., Zhang L.Fuentes:scopusHER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy
ArticleAbstract: (Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tiPalabras claves:Affibodies, Antitumor agents, Nanoparticles, PLA-PEG copolymers, Targeted therapyAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Levy-Nissenbaum E., Marein S.L., Molnar L.K., Pridgen E.M., Radovic-Moreno A.F., Wang A.Z., Westerhof K., Zhang L.Fuentes:scopusSuperparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy
ArticleAbstract: (Chemical Equation Presented) Multifunctional superparamagnetic iron oxide nanoparticles: Herein wePalabras claves:doxorubicin, Nanoparticles, Superparamagnetic, TCL-SPIONAutores:Bagalkot V., Bander N.H., Cima M.J., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Kantoff P.W., Langer R.S., Shaikh M., Vasilliou C.C., Wang A.Z., Yuet K., Zhang L.Fuentes:scopus